title: Ovarian failure following cancer treatment: current management and quality of life.
abstract: BACKGROUND
  There is a lack of evidence regarding current screening practices for incipient ovarian failure in young women following gonadotoxic therapy and the most appropriate form of estrogen replacement. This study examined the (i) prevalence and management of ovarian failure and (ii) quality-of-life implications of early menopause (EM).
  
  
  METHODS
  A medical case note audit for 288 women with a history of gonadotoxic therapy (aged 18-50 years) was conducted. Self-reported quality-of-life data were obtained from 178 (62%).
  
  
  RESULTS
  Ovarian screening was recorded in 44% of medical case notes, and ovarian failure was documented for 35%. From the self-reported data, 89/178 (50%) women reported experiencing an EM/ovarian failure. Worse menopausal symptoms were negatively associated with both sexual activity [pleasure (r = 0.29, P < 0.01), discomfort (r = 0.50, P < 0.001) and habit (r = 0.22, P < 0.05)] and general quality of life (P = 0.01). Hormone replacement therapy is the most commonly prescribed estrogen preparation; however, 34% of women with EM/ovarian failure reported not taking any replacement therapy.
  
  
  CONCLUSIONS
  Given the extent and impact of menopausal symptoms, further work is needed to establish systems for screening ovarian function and to determine appropriate and effective management of ovarian failure.
authors.affiliation: Department of Psychology, University of Sheffield, Western Bank, Sheffield S10 2TP, UK.
authors.forename: Kate
authors.initials: K
authors.lastname: Absolom
authors.forename: Christine
authors.initials: C
authors.lastname: Eiser
authors.forename: Lesley
authors.initials: L
authors.lastname: Turner
authors.forename: William
authors.initials: W
authors.lastname: Ledger
authors.forename: Richard
authors.initials: R
authors.lastname: Ross
authors.forename: Helena
authors.initials: H
authors.lastname: Davies
authors.forename: Robert
authors.initials: R
authors.lastname: Coleman
authors.forename: Barry
authors.initials: B
authors.lastname: Hancock
authors.forename: John
authors.initials: J
authors.lastname: Snowden
authors.forename: Diana
authors.initials: D
authors.lastname: Greenfield
mesh_terms: D000293:Adolescent; D000328:Adult; D015331:Cohort Studies; D015914:Estrogen Replacement Therapy; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008593:Menopause; D008594:Menopause, Premature; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications* / Q000628:therapy*; D016649:Primary Ovarian Insufficiency / Q000209:etiology* / Q000523:psychology / Q000628:therapy*; D011788:Quality of Life; D012044:Regression Analysis; D012725:Sexual Behavior
chemical_list: D004967:Estrogens